journal article·2024-07

Activating Macrophage Continual Efferocytosis via Microenvironment Biomimetic Short Fibers for Reversing Inflammation in Bone Repair

Haoran Wang, Yu Zhang, Yipu Zhang, Chao Li, Mo Zhang, Juan Wang, Yingze Zhang, Yawei Du, Wenguo Cui, Wei Chen

Advanced Materials· Volume 36· Issue 30
Publisher page

Abstract

Abstract Efferocytosis‐mediated inflammatory reversal plays a crucial role in bone repairing process. However, in refractory bone defects, the macrophage continual efferocytosis may be suppressed due to the disrupted microenvironment homeostasis, particularly the loss of apoptotic signals and overactivation of intracellular oxidative stress. In this study, a polydopamine‐coated short fiber matrix containing biomimetic “apoptotic signals” to reconstruct the microenvironment and reactivate macrophage continual efferocytosis for inflammatory reversal and bone defect repair is presented. The “apoptotic signals” (AM/CeO2) are prepared using CeO2 nanoenzymes with apoptotic neutrophil membrane coating for macrophage recognition and oxidative stress regulation. Additionally, a short fiber “biomimetic matrix” is utilized for loading AM/CeO2 signals via abundant adhesion sites involving π–π stacking and hydrogen bonding interactions. Ultimately, the implantable apoptosis‐mimetic nanoenzyme/short‐fiber matrixes (PFS@AM/CeO2), integrating apoptotic signals and biomimetic matrixes, are constructed to facilitate inflammatory reversal and reestablish the pro‐efferocytosis microenvironment. In vitro and in vivo data indicate that the microenvironment biomimetic short fibers can activate macrophage continual efferocytosis, leading to the suppression of overactivated inflammation. The enhanced repair of rat femoral defect further demonstrates the osteogenic potential of the pro‐efferocytosis strategy. It is believed that the regulation of macrophage efferocytosis through microenvironment biomimetic materials can provide a new perspective for tissue repair.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Graphene and Nanomaterials Applications · Extracellular vesicles in disease · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Orthopaedic Surgery the Hebei Medical University Third Hospital Key Laboratory of Biomechanics of Hebei Province Orthopaedic Research Institution of Hebei Province NHC Key Laboratory of Intelligent Orthopaedic Equipment No.139 Ziqiang Road Shijiazhuang 050051 P. R. China

Department of Orthopaedics Shanghai Key Laboratory for Prevention and Treatment of Bone and Joint Diseases Shanghai Institute of Traumatology and Orthopaedics Ruijin Hospital Shanghai Jiao Tong University School of Medicine 197 Ruijin 2nd Road Shanghai 200025 P. R. China

Department of Orthopaedics Peking University Third Hospital 49 North Garden Road, Haidian District Beijing 100191 P. R. China

Funding

Shanghai Municipal Health Commission · Natural Science Foundation of Hebei Province · Key Technologies Research and Development Program · National Natural Science Foundation of China

References (86)

Show source-provided references
1. 10.1038/s41573-022-00470-y10.1038/s41573-022-00470-y ↗
2. 10.1016/j.cmet.2021.08.00110.1016/j.cmet.2021.08.001 ↗
3. 10.1038/s42255-023-00736-810.1038/s42255-023-00736-8 ↗
4. 10.1016/j.actbio.2021.04.05210.1016/j.actbio.2021.04.052 ↗
5. 10.3390/cells1303020810.3390/cells13030208 ↗
6. 10.1002/SMMD.2023003610.1002/SMMD.20230036 ↗
7. 10.1016/j.cmet.2020.01.00110.1016/j.cmet.2020.01.001 ↗
8. 10.1016/j.actbio.2021.07.00210.1016/j.actbio.2021.07.002 ↗
9. 10.1016/j.cmet.2018.12.00410.1016/j.cmet.2018.12.004 ↗
10. 10.1161/CIRCULATIONAHA.121.05754910.1161/CIRCULATIONAHA.121.057549 ↗
11. 10.1016/j.jot.2022.04.00210.1016/j.jot.2022.04.002 ↗
12. 10.1172/JCI15949810.1172/JCI159498 ↗
13. 10.1182/blood.202201591710.1182/blood.2022015917 ↗
14. 10.1002/adfm.20220026010.1002/adfm.202200260 ↗
15. 10.1016/j.cmet.2021.10.01510.1016/j.cmet.2021.10.015 ↗
16. 10.1021/acsnano.3c0381510.1021/acsnano.3c03815 ↗
17. 10.2147/IJN.S17699110.2147/IJN.S176991 ↗
18. 10.1016/j.matdes.2023.11230510.1016/j.matdes.2023.112305 ↗
19. 10.1016/j.actbio.2020.03.04110.1016/j.actbio.2020.03.041 ↗
20. 10.1016/j.scib.2023.03.03010.1016/j.scib.2023.03.030 ↗
21. 10.1016/j.jconrel.2020.09.02310.1016/j.jconrel.2020.09.023 ↗
22. 10.1002/adfm.20220106710.1002/adfm.202201067 ↗
23. 10.1111/j.1600-065X.2010.00922.x10.1111/j.1600-065X.2010.00922.x ↗
24. 10.1016/j.bioactmat.2021.03.03910.1016/j.bioactmat.2021.03.039 ↗
25. 10.3390/antiox1002031310.3390/antiox10020313 ↗
26. 10.1164/rccm.200807-1148OC10.1164/rccm.200807-1148OC ↗
27. 10.1172/JCI16707910.1172/JCI167079 ↗
28. 10.2147/IJN.S27022910.2147/IJN.S270229 ↗
29. 10.1002/adma.20221121010.1002/adma.202211210 ↗
30. Li J. · Adv. Mater. · 2018 · 5
31. 10.2147/IJN.S25774110.2147/IJN.S257741 ↗
32. 10.1002/SMMD.2023001710.1002/SMMD.20230017 ↗
33. 10.1002/adhm.20220304710.1002/adhm.202203047 ↗
34. 10.1016/j.bmt.2022.11.00910.1016/j.bmt.2022.11.009 ↗
35. 10.1016/j.bmt.2023.10.00110.1016/j.bmt.2023.10.001 ↗
36. 10.1016/j.bmt.2023.05.00210.1016/j.bmt.2023.05.002 ↗
37. 10.1016/j.engreg.2023.10.00310.1016/j.engreg.2023.10.003 ↗
38. 10.1016/j.biomaterials.2022.12153810.1016/j.biomaterials.2022.121538 ↗
39. 10.1016/j.msec.2021.11204110.1016/j.msec.2021.112041 ↗
40. 10.1016/j.cell.2017.08.04110.1016/j.cell.2017.08.041 ↗
41. 10.1007/s42765-022-00229-510.1007/s42765-022-00229-5 ↗
42. 10.1002/adma.20210832510.1002/adma.202108325 ↗
43. 10.1016/j.biomaterials.2021.12103710.1016/j.biomaterials.2021.121037 ↗
44. 10.1016/j.engreg.2020.07.00210.1016/j.engreg.2020.07.002 ↗
45. 10.1016/j.bmt.2023.05.00110.1016/j.bmt.2023.05.001 ↗
46. 10.1126/sciadv.abc203610.1126/sciadv.abc2036 ↗
47. 10.1016/j.cis.2022.10268910.1016/j.cis.2022.102689 ↗
48. 10.1016/j.biomaterials.2009.12.02010.1016/j.biomaterials.2009.12.020 ↗
49. 10.1016/j.engreg.2022.09.00410.1016/j.engreg.2022.09.004 ↗
50. 10.1002/adma.20230280110.1002/adma.202302801 ↗
51. 10.1007/s40820-019-0330-910.1007/s40820-019-0330-9 ↗
52. 10.1002/adma.20170675910.1002/adma.201706759 ↗
53. 10.1016/j.jconrel.2015.07.01910.1016/j.jconrel.2015.07.019 ↗
54. 10.1038/s41565-018-0254-410.1038/s41565-018-0254-4 ↗
55. 10.1016/j.bmt.2023.01.00110.1016/j.bmt.2023.01.001 ↗
56. 10.1021/acsami.9b0890110.1021/acsami.9b08901 ↗
57. 10.1016/j.ijpharm.2018.08.01010.1016/j.ijpharm.2018.08.010 ↗
58. 10.1002/EXP.2022004510.1002/EXP.20220045 ↗
59. 10.1002/smll.20220030610.1002/smll.202200306 ↗
60. 10.1021/acsami.2c1386810.1021/acsami.2c13868 ↗
61. 10.1002/EXP.2021002910.1002/EXP.20210029 ↗
62. 10.1016/j.scib.2024.03.01310.1016/j.scib.2024.03.013 ↗
63. 10.1021/acsami.9b1574010.1021/acsami.9b15740 ↗
64. 10.1016/j.msec.2021.11258910.1016/j.msec.2021.112589 ↗
65. 10.1002/SMMD.2023002410.1002/SMMD.20230024 ↗
66. 10.1002/SMMD.2022001310.1002/SMMD.20220013 ↗
67. 10.1038/s41467-021-27816-110.1038/s41467-021-27816-1 ↗
68. 10.34133/2022/982378410.34133/2022/9823784 ↗
69. 10.1016/j.engreg.2020.05.00310.1016/j.engreg.2020.05.003 ↗
70. 10.1016/j.biomaterials.2021.12111410.1016/j.biomaterials.2021.121114 ↗
71. 10.1038/nrrheum.2012.110.1038/nrrheum.2012.1 ↗
72. 10.1016/j.bone.2022.11638910.1016/j.bone.2022.116389 ↗
73. 10.1002/adma.20220878110.1002/adma.202208781 ↗
74. 10.1002/adfm.20211100310.1002/adfm.202111003 ↗
75. 10.1016/j.pharmthera.2022.10828210.1016/j.pharmthera.2022.108282 ↗
76. 10.1126/scisignal.abn137210.1126/scisignal.abn1372 ↗
77. 10.1002/smll.20220691910.1002/smll.202206919 ↗
78. 10.1016/j.biomaterials.2022.12157410.1016/j.biomaterials.2022.121574 ↗
79. 10.1016/j.celrep.2021.11022210.1016/j.celrep.2021.110222 ↗
80. 10.34133/research.023910.34133/research.0239 ↗
81. 10.1088/2752-5724/ac39ff10.1088/2752-5724/ac39ff ↗
82. 10.1016/j.bioactmat.2021.08.00810.1016/j.bioactmat.2021.08.008 ↗
83. 10.1016/j.isci.2023.10791610.1016/j.isci.2023.107916 ↗
84. 10.1002/smll.20220079910.1002/smll.202200799 ↗
85. 10.1016/j.colsurfb.2021.11197210.1016/j.colsurfb.2021.111972 ↗
86. 10.1016/j.bioactmat.2021.05.02410.1016/j.bioactmat.2021.05.024 ↗